Artal Group S.A. reduced its position in shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 27.5% in the second quarter, Holdings Channel reports. The firm owned 1,213,725 shares of the company’s stock after selling 460,018 shares during the period. Artal Group S.A.’s holdings in Relay Therapeutics were worth $15,244,000 at the end of […]
Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the ten research firms that are currently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has issued a strong […]
Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) has earned an average recommendation of “Moderate Buy” from the ten research firms that are covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation, seven have issued a buy recommendation and one has assigned a strong buy recommendation to the […]
Relay Therapeutics (NASDAQ:RLAY – Free Report) had its price objective cut by HC Wainwright from $33.00 to $19.00 in a report released on Wednesday morning, Benzinga reports. They currently have a buy rating on the stock. A number of other analysts have also weighed in on the stock. Oppenheimer reaffirmed an outperform rating and issued […]